Plain-English translation of NCT03981276 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a long-term study that aims to better understand hereditary spastic paraplegia — a rare condition affecting the nerves that control leg movement — by following patients and their families over many years. Researchers will perform standardized clinical exams, collect optional blood or tissue samples, and gather information into a shared database to identify patterns, discover new biomarkers, and understand how the disease progresses.
Hereditary spastic paraplegia is a rare and complex disorder, and doctors still don't fully understand how and why it develops or how to predict its course in individual patients. By collecting information and samples from many patients over time, this study aims to identify new insights into the disease that could eventually lead to better treatments and earlier diagnosis.
You likely qualify if…
You likely don't qualify if…
You would visit the study site once a year for a standardized clinical exam, during which doctors will assess your symptoms using rating scales tailored to your condition. At each visit, you'll be asked to donate optional biosamples — such as blood, urine, cerebrospinal fluid, or a small skin sample — which researchers can use to study disease markers. Depending on your individual needs, you may also have imaging, movement analysis, or other specialized tests, and your clinical information will be entered into a shared research database called the HSP Registry.
AI-generated summary from trial data · Jun 10, 2026 · Not medical advice
Austria
Germany